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 Red blood cell exchange with peripheral venous 
access in a patient with sickle cell anemia and stroke
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Resumen
La drepanocitosis es la enfermedad huérfana más 
frecuente en el Valle del Cauca, se estima que es la 
principal causa de muerte por enfermedades huérfanas 
en Colombia en población que se autodenomina 
como afrocolombiana y mulata. El accidente cerebro 
vascular isquémico es una de las complicaciones más 
devastadoras de la enfermedad, su tratamiento requiere 
el empleo de recambio hemático automatizado el cual 
no se ha reportado hasta el momento en Colombia. El 
acceso venoso en los procedimientos de aféresis puede 
constituir una barrera de acceso y de oportunidad a la 
terapia. Se describe el caso de un paciente de 15 años con 
diagnóstico de drepanocitosis (HbSS) quien consultó a 
urgencias por presentar hemiparesia izquierda (fuerza 
3/5), crisis dolorosa (escala visual análoga 10/10), con 
una tomografía axial computarizada que evidenciaba 
un accidente cerebrovascular isquémico. La última 
electroforesis de hemoglobina mostró un porcentaje de 
hemoglobina S del 95% y una hemoglobina de 10,5 g/
dl. El servicio de hematología pediátrica consideró este 
escenario una indicación de recambio hemático, el cual 
se realizó con acceso venoso periférico requiriendo 12 
unidades de glóbulos rojos leucorreducidos, fenotipados 
para el Rh y kell y compatibles y se utilizó la máquina 
Optia Spectra®. A las 48 horas el paciente presenta 
mejoría del dolor (escala visual análoga 0/10) y 
mejoría de la hemiparesia (fuerza 4/5), la electroforesis 
de hemoglobina S mostró un porcentaje del 8%. En 
Colombia es el primer caso descrito en la literatura de 
recambio hemático en un paciente con drepanocitosis 
con acceso venoso periférico y resultados exitosos. 
Palabras clave: Drepanocitosis, Transfusión, 
Enfermedades cerebrovasculares, Hemoglobinopatía.
Abstract
Sickle cell disease is the most frequent orphan disease 
in Valle del Cauca, it is estimated that it is the main 
cause of death from orphan diseases in Colombia 
in a population that calls itself Afro-Colombian and 
mulatto. Ischemic stroke is one of the most devastating 
complications of the disease, its treatment requires 
the use of Red blood cell exchange (RBCX) which 
has not been reported in Colombia. Venous access in 
apheresis procedures can constitute a barrier to access 
and opportunity to this therapy. We describe the case 
of a 15-year-old patient with diagnosis of sickle cell 
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disease (HbSS) who consulted the emergency room for 
presenting left hemiparesis (strength 3/5), painful crisis 
(visual analogue scale 10/10), with a computerized axial 
tomography that showed an ischemic stroke. The last 
hemoglobin electrophoresis showed a hemoglobin S 
percentage of 95% and a hemoglobin of 10.5 g / dl. The 
pediatric hematology service considered this scenario 
an indication for Red blood cell exchange (RBCX), 
which was performed with peripheral venous access 
requiring 12 units of leukoreduced packed red blood 
cells, phenotyped for Rh and kell and cross-matched, 
and the Optia Spectra® machine was used. At 48 hours, 
the patient presented pain relief (0/10 visual analog 
scale) and hemiparesis improvement (4/5 strength), 
the hemoglobin electrophoresis showed a hemoglobin S 
percentage of 8% afther the procedure. In Colombia, this 
is the first case described in the literature of Red blood 
cell exchange (RBCX) in a patient with sickle cell disease 
with peripheral venous access and successful results.
Keywords: Anemia, Sickle Cell, Erythrocyte, 
Transfusion, Stroke, Hemoglobinopathy.
Introduction 
Sickle cell disease is a public health problem 
in Colombia, it is estimated that in Valle del 
Cauca approximately 4.5% of newborns are 
at least heterozygous for the hemoglobin S 
gene1. Therefore, the Colombian regulations 
declared it an orphan disease and began its 
surveillance through the National Institute 
of Health2, unfortunately it is the cause of 
82.7% of deaths from orphan diseases in the 
population that is recognized as mulatto, 
Afro-Colombian or Afro-descendant3. Sickle 
cell disease like other hemoglobinopathies 
is the result of human interaction with the 
parasite of the genus Plasmodium that 
cause of malaria, since this mutation confers 
resistance to infection and has occurred at 
least 5 times in the history of humanity in 
independent populations and without genetic 
flow between them4.
The complications of the disease are 
systemic, they include an increased risk of 
suffering from pneumonia, asthma attacks, 
kidney failure, invasive infections by 
encapsulated microorganisms, meningitis 
and cerebrovascular accidents, among others5. 
The most feared complications and of recent 
attention are silent cerebrovascular infarcts 
that can occur in up to 35% of patients, 
cognitive impairment and non-silent cerebral 
infarcts which are associated with a significant 
deterioration of functional capacity and quality 
of life6. Therapeutic strategies consist of chronic 
red blood cell transfusions and Red blood cell 
exchange in order to reduce the percentage of 
hemoglobin S to a value less than 30%7. One 
of the main technical difficulties of the Red 
blood cell exchange lies in the need for central 
venous access to connect automated blood 
exchange devices to patients8,9. However, 
advances in technology are capable to perform 
apheresis procedures with peripheral venous 
access, thus reducing administrative barriers, 
costs, improving patient safety and optimizing 
the cost-utility and cost-effectiveness of care10. 
This article describes the treatment of a 
patient with a diagnosis of sickle cell disease 
and cerebral infarction who was successfully 
treated with blood exchange in the first 12 
hours of care with peripheral venous access in 
the upper limbs.
Case Description 
A 15-year-old male patient, originally 
from and from the municipality of Florida, 
Valle del Cauca, diagnosed with sickle cell 
disease (HbSS) on September 17, 2017, with 
a hemoglobin S percentage of 95%, with 
poor adherence to the treatment and no 
medical control. In July 2019 consulted at the 
local emergency room in his municipality 
for presenting 6 days of left hemiparesis 
associated with intense musculoskeletal pain, 
with an intensity on the visual-analog scale 
of 10/10, upon physical examination the 
patient was admitted with blood pressure 
100/60, heart rate 110 beats per minute, 
respiratory rate 24 beats per minute and 
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temperature 37.5° C. The thorax presented 
bilateral normoexpansion, no dullness to 
percussion, vesicular murmurs were heard 
in all lung fields, no egophony or whispered 
pectoriloquism was evidenced. A point of 
maximum intensity was palpated in the left 
midclavicular line, no thrill or turbulence was 
palpated, the heart sounds were rhythmic 
and regular without murmurs, the first and 
second sounds were reinforced, S3 was not 
auscultated, no murmurs were evidenced in 
the aortic mitral focus, pulmonary or tricuspid. 
The abdomen presented preserved air-fluid 
sounds, no signs of peritoneal irritation such 
as Blombeg, Rovsign, McBurney, rebound, 
psoas sign, thallus percussion were evident. 
The Murphy was negative. Costovertebral 
percussion was negative, as was renal 
percussion. The ascites wave was negative. 
Hepatomegaly and splenomegaly were 
negative. Neurological examination revealed 
left hemiparesis with a strength of 3/5 without 
cranial nerve involvement and left patellar 
and achillian hyporeflexia, without signs of 
meningeal irritation such as nuchal rigidity, 
Kernig or Brudzinski. 
He is immediately referred to the Hospital 
Universitario del Valle, in the emergency 
service of this institution he is evaluated by 
pediatric neurology and hematology who 
find a patient with the described neurological 
deficit. Supportive medical management 
with intravenous fluids, morphine, high-
flow oxygen was provided and requested a 
simple cerebral computed tomography scan 
and blood tests. The hemogram showed 
15,130 leukocytes / μL, hematocrit 34.4%, 
hemoglobin 10.7 g / dl, platelets 583,000 per 
microliter, in the peripheral blood smear 
sickle cells were found. Clotting times 
were normal. Bilirubins were high, lactate 
dehydrogenase in normal ranges, as were 
electrolytes and creatinine. The computerized 
axial tomography revealed a focal hypodense 
area that compromised the body of the caudate 
nucleus and the anterior arm and part of the 
posterior arm of the internal capsule on the 
right side, in relation to the acute ischemic 
infarct (Figure 1). He was reassessed by the 
pediatric hematology service who considered 
performing automated blood exchange. The 
patient was transferred from the emergency 
room to the hematology hospitalization 
service where the vasculature of the upper 
limbs was evaluated and the nurse obtained 
intravenous access through cannulation of the 
antecubital veins. The patient was connected 
to the Optia Spectra(R) machine.  Based in the 
previous hemoglobin S percentage, height and 
weigth, an erythorcyte volume of 3200 ml was 
calculated for a final hematocrit of 30%. The 
duration of the procedure was 3 hours, the flow 
was 45ml/minute and 12  units of packed red 
cell blood cells, leukoreduced, isophenotype 
for Rh and kell of  were required. There were 
no adverse reactions to the transfusion, the 
patient tolerated the procedure satisfactorily.
Figure 1. Simple computerized axial
 tomography of the brain
Source: Radiology Service of the Hospital 
Universitario del Valle.
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Simple brain tomography showing a focal 
hypodense area that involves the body of the 
caudate nucleus and the anterior arm and part 
of the posterior arm of the internal capsule on 
the right side, in relation to an acute ischemic 
focus (red ellipse). 
48 hours after the procedure, a new 
hemoglobin electrophoresis was performed, 
which reported a hemoglobin S percentage 
of 8% with absolute pain relief (0/10 visual 
analogue scale) without the need for opioid 
analgesics. On physical examination he 
persisted with left hemiparesis, but with 
improvement (strength in left hemibody 4/5). 
The hemogram reported hemoglobin of 10.5 
g / dl and hematocrit of 30%. It is evaluated 
by physical medicine and rehabilitation who 
considered that the patient achieved progress 
and physical and occupational therapy was 
ordered in order to avoid loss of functional 
capacity and independence in activities of 
daily living.
Discussion 
Red blood cell exchange (RBCX) in the 
treatment of sickle cell disease is a widespread 
practice in high-income countries, in the 
United Kingdom it is estimated that the use of 
existing machines will save that health system 
13 million pounds9,10
. In Colombia, this is the first reported 
case of the use of blood exchange and its 
implementation with peripheral venous 
access in a patient with ischemic stroke, which, 
since it can be performed with peripheral 
catheters (Introcan Safety® 3 18G), reduces 
access barriers. In the present case, the use 
with the greatest evidence of automated blood 
exchange is shown, since its superiority over 
simple transfusion has been demonstrated 
in terms of mortality, technical efficiency (it 
allows achieving a hemoglobin S goal of less 
than 30%) and ease of operation in sickle 
cell patients with ischemic strokes11. Red 
blood cell exchange, poses challenges, firstly 
including it among specialists as a therapeutic 
tool. Secondly adapting the installed capacity 
of health services from the south west of 
Colombia. Thirdly, the demand and effort on 
the part of civil society to satisfy the demand 
for blood required by the procedure. Lastly, 
the standardization of a clinical practice guide 
that includes and disseminates it 10. Despite the 
fact that the present case represents an advance 
in treatment, sickle cell disease persists as a 
public health problem11. The case described 
shows how the social determinants of health 
impact on access to treatment of the disease, 
which includes rapid dispensing of drugs 
(which in Colombia is precarious), access 
and opportunity to medical consultation with 
specialists who are experts in the disease, since 
the patient lost contact with the health system. 
This highlights the importance of a primary 
health care approach that includes orphan 
diseases within the collective imagination 
of the population, which allows decent 
and quality care for patients. In this sense, 
Colombia lags behind other countries where 
strategies and programs have been established 
that range from neonatal screening to work 
and community integration of patients12,13.
Conclusions
Automated blood exchange with peripheral 
venous access as a therapeutic tool allowed 
the treatment of one of the most devastating 
complications of sickle cell disease in a young 
patient who presented with an ischemic 
stroke.
 Patient perspective
The patient refers that the blood exchange 
improved the pain and he sees the importance 
of carrying out the medical controls “if it 
took away the pain I must return to medical 
control”, however, he also refers to fear of 
discrimination in the school environment “I 
want to go back to school I’m in the seventh 
year of high school and I haven’t been able 
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to continue because the pain didn’t leave me, 
but I don’t want them to make fun of me ”.
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